Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) EBIT Margin (2022 - 2025)

Historic EBIT Margin for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to 258.82%.

  • Neuraxis' EBIT Margin fell 111100.0% to 258.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 225.43%, marking a year-over-year increase of 723200.0%. This contributed to the annual value of 266.46% for FY2024, which is 44500.0% up from last year.
  • As of Q3 2025, Neuraxis' EBIT Margin stood at 258.82%, which was down 111100.0% from 192.14% recorded in Q2 2025.
  • Neuraxis' 5-year EBIT Margin high stood at 98.1% for Q2 2022, and its period low was 633.0% during Q3 2023.
  • Over the past 4 years, Neuraxis' median EBIT Margin value was 221.07% (recorded in 2022), while the average stood at 247.71%.
  • Its EBIT Margin has fluctuated over the past 5 years, first plummeted by -4385800bps in 2023, then skyrocketed by 3853000bps in 2024.
  • Quarter analysis of 4 years shows Neuraxis' EBIT Margin stood at 160.86% in 2022, then crashed by -90bps to 305.42% in 2023, then skyrocketed by 37bps to 192.68% in 2024, then plummeted by -34bps to 258.82% in 2025.
  • Its EBIT Margin was 258.82% in Q3 2025, compared to 192.14% in Q2 2025 and 256.25% in Q1 2025.